Cargando…

(193) Coping with SARS-CoV-2-induced ARDS

Detalles Bibliográficos
Autores principales:	Pancharovski, Tawnya, Bhasin, Shreya, Choi, Joy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646371/ http://dx.doi.org/10.1016/j.jaclp.2022.10.195

Ejemplares similares

Defibrotide Therapy for SARS-CoV-2 ARDS
por: Frame, David, et al.
Publicado: (2022)

Use of Spironolactone in SARS-CoV-2 ARDS Patients
por: Dumanlı, Güleren Yartaş, et al.
Publicado: (2020)

Specific Treatment Exists for SARS-CoV-2 ARDS
por: Kanwar, Badar, et al.
Publicado: (2021)

Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS
por: Mueller-Peltzer, Katharina, et al.
Publicado: (2020)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2020)

Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study
por: Schlesinger, Tobias, et al.
Publicado: (2020)

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS
por: Juanes-Velasco, Pablo, et al.
Publicado: (2022)

Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
por: Cure, Erkan, et al.
Publicado: (2020)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS
por: Lupu, Ludmila, et al.
Publicado: (2020)

SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
por: Reizine, Florian, et al.
Publicado: (2021)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
por: McElvaney, Oisin F., et al.
Publicado: (2022)

Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2
por: Pagano, A., et al.
Publicado: (2020)

Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
por: Mahendiratta, Saniya, et al.
Publicado: (2021)

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

SARS-CoV-2 related ARDS and invasive fungal infections in intensive care patients
por: Borg, Darren, et al.
Publicado: (2022)

Platypnea-orthodeoxia syndrome in SARS-CoV-2 related ARDS: a case report
por: Aprea, Concetta, et al.
Publicado: (2022)

SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients
por: Buetti, Niccolò, et al.
Publicado: (2020)

Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2
por: Baedorf Kassis, Elias, et al.
Publicado: (2021)

Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients
por: Redant, Sébastien, et al.
Publicado: (2020)

Effect of the duration of prone position in ARDS patients during the SARS-CoV-2 pandemic()
por: de Miguel-Balsa, Eva, et al.
Publicado: (2023)

Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants
por: Zhang, Lianghui, et al.
Publicado: (2021)

SARS-CoV-2 RNA in Explant Lung Tissue from Patients with COVID-19 ARDS
por: Van Slambrouck, J., et al.
Publicado: (2022)

Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
por: Zheng, Jiajing, et al.
Publicado: (2022)

Validation of the P/FPE index in a cohort of patients with ARDS due to SARS-CoV-2
por: González-Castro, Alejandro, et al.
Publicado: (2023)

Subphenotypes of SARS-CoV-2-Associated ARDS Overlap Each Other: A Retrospective Analysis
por: Nair, Parvathy R., et al.
Publicado: (2023)

HMGB1: A Potential Target of Nervus Vagus Stimulation in Pediatric SARS-CoV-2-Induced ALI/ARDS
por: Jankauskaite, Lina, et al.
Publicado: (2022)

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

Management of severe ARDS due to SARS-CoV-2 pneumonia using low-flow extracorporeal CO(2) extraction
por: Molina Lobo, Rosario, et al.
Publicado: (2021)

Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection()
por: García-Hidalgo, María C., et al.
Publicado: (2022)

Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS
por: García-Hidalgo, María C., et al.
Publicado: (2022)

Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets
por: Karmouty-Quintana, Harry, et al.
Publicado: (2020)

Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation
por: Staszewski, Cara, et al.
Publicado: (2022)

Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.
por: Balnis, Joseph, et al.
Publicado: (2020)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

SARS-CoV-2 Pandemic and Food Safety Oversight: Implications in Canada and Coping Strategies
por: Charlebois, Sylvain, et al.
Publicado: (2021)

Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine
por: Galli, Gloria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fua7i50i7a4rjbjmk8sn6020vg